Baxter International Inc
XETRA:BTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Baxter International Inc
XETRA:BTL
|
US |
|
Qualigen Therapeutics Inc
NASDAQ:AIXC
|
US |
|
E
|
Edenred SE
XBER:QSV
|
FR |
|
Jerash Holdings (US) Inc
NASDAQ:JRSH
|
US |
|
Titagarh Wagons Ltd
NSE:TWL
|
IN |
|
A
|
American Scientific Resources Inc
OTC:ASFX
|
US |
|
Hemnet Group AB (publ)
OTC:HEMNF
|
SE |
Wall St Price Targets
BTL Price Targets Summary
Baxter International Inc
According to Wall Street analysts, the average 1-year price target for BTL is 50.92 EUR with a low forecast of 35.93 EUR and a high forecast of 105.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BTL's stock price target?
Price Target
50.92
EUR
According to Wall Street analysts, the average 1-year price target for BTL is 50.92 EUR with a low forecast of 35.93 EUR and a high forecast of 105.1 EUR.
What is the Revenue forecast for Baxter International Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 5 years is 3%.
What is the Gross Profit forecast for Baxter International Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Baxter International Inc?
Projected CAGR
58%
Over the last 13 years, the compound annual growth rate for Operating Income has been -14%. The projected CAGR for the next 3 years is 58%.
